TACSTD2 and cancer: CRCs exhibiting an elevated or high degree of tumour budding [24, 26, 41] – an unfavourable histopathological parameter assessing a cancer's capacity for dissociative growth – demonstrated a significantly greater prevalence of TROP2 expression compared with CRCs without dissociative growth.